Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation

American Journal of Roentgenology

Volumn 197, Issue 2, 2011, Pages

  Baek, Jung Hwan ^a,b   Kim, Yoon Suk ^a   Sung, Jin Yong ^a   Choi, Hoon ^a   Lee, Jeong Hyun ^b  

^a The Catholic University of Korea   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Ethanol ablation; Radiofrequency ablation; Recurrent thyroid cancer; Thyroid intervention

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DIFFERENTIATED THYROID CANCER; DYSPHONIA; ELECTRODE; FEMALE; FOLLOW UP; HUMAN; MALE; METASTASIS; METASTASIS POTENTIAL; PATIENT SAFETY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TREATMENT DURATION; TUMOR REGRESSION; TUMOR VOLUME; ULTRASOUND GUIDED RADIOFREQUENCY ABLATION;

ADULT; AGED; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; CATHETER ABLATION; ELECTRODES; EQUIPMENT DESIGN; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 79960706011     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.5345     Document Type: Article

References (29)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51:15-36 (Pubitemid 32166444)
2. Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992; 164:658-661
3. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988; 104:947-953 (Pubitemid 19011971)
4. Kim BM, Kim MJ, Kim EK, Park SI, Park CS, Chung WY. Controlling recurrent papillary thyroid carcinoma in the neck by ultrasonography-guided percutaneous ethanol injection. Eur Radiol 2008; 18:835-842 (Pubitemid 351447779)
5. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114:1050-1057; discussion 1057-1058
6. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16:109-142
7. Ekman ET, Lundell G, Tennvall J, Wallin G. Chemotherapy and multimodality treatment in thyroid carcinoma. Otolaryngol Clin North Am 1990; 23:523-527 (Pubitemid 20194777)
8. Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992; 75:714-720
9. Lewis BD, Hay ID, Charboneau JW, McIver B, Reading CC, Goellner JR. Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. AJR 2002; 178:699-704 (Pubitemid 34178153)
10. Lim CY, Yun JS, Lee J, Nam KH, Chung WY, Park CS. Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma. Thyroid 2007; 17:347-350 (Pubitemid 46776139)
11. Monchik JM, Donatini G, Iannuccilli J, Dupuy DE. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 2006; 244:296-304 (Pubitemid 44305546)
12. Dodd GD 3rd, Soulen MC, Kane RA, et al. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. RadioGraphics 2000; 20:9-27
13. Dupuy DE, Monchik J, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery 2001; 130:971-977 (Pubitemid 34014562)
14. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities-part II. J Vasc Interv Radiol 2001; 12:1135-1148 (Pubitemid 32983350)
15. Goldberg SN. Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound 2001; 13:129-147 (Pubitemid 32463283)
16. Kang TW, Rhim H, Kim EY, et al. Percutaneous radiofrequency ablation for the hepatocellular carcinoma abutting the diaphragm: assessment of safety and therapeutic efficacy. Korean J Radiol 2009; 10:34-42
17. Baek JH, Kim YS, Lee D, Huh JY, Lee JH. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR 2010; 194:1137-1142
18. Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 2008; 18:1244-1250
19. Kim YS, Rhim H, Tae K, Park DW, Kim ST. Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience. Thyroid 2006; 16:361-367
20. Deandrea M, Limone P, Basso E, et al. US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol 2008; 34:784-791 (Pubitemid 351621898)
21. Spiezia S, Garberoglio R, Milone F, et al. Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid 2009; 19:219-225
22. Lee JH, Kim YS, Lee D, Choi H, Yoo H, Baek JH. Radiofrequency ablation (RFA) of benign thyroid nodules in patients with incompletely resolved clinical problems after ethanol ablation (EA). World J Surg 2010; 34:1488-1493
23. Baek JH, Moon WJ, Kim YS, Lee JH, Lee D. Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World J Surg 2009; 33:1971-1977
24. Baek JH, Jeong HJ, Kim YS, Kwak MS, Lee D. Radiofrequency ablation for an autonomously functioning thyroid nodule. Thyroid 2008; 18:675-676 (Pubitemid 351918445)
25. Jeon SJ, Kim E, Park JS, et al. Diagnostic benefit of thyroglobulin measurement in fine-needle aspiration for diagnosing metastatic cervical lymph nodes from papillary thyroid cancer: correlations with US features. Korean J Radiol 2009; 10:106-111
26. Cho YK, Kim JK, Kim MY, Rhim H, Han JK. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009; 49:453-459
27. Ikeda M, Okada S, Ueno H, Okusaka T, Kuriyama H. Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study. Jpn J Clin Oncol 2001; 31:322-326 (Pubitemid 32791460)
28. Giovagnorio F, Martinoli C. Sonography of the cervical vagus nerve: normal appearance and abnormal findings. AJR 2001; 176:745-749 (Pubitemid 32181978)
29. Tubbs RS, Loukas M, Shoja MM, et al. An unreported variation of the cervical vagus nerve: anatomical and histological observations. Folia Morphol (Warsz) 2007; 66:155-157 (Pubitemid 46939337)